The Lustgarten Foundation announced today that it funded $22 million in 2017 as part of its commitment to invest $40 million by the end of 2018. In addition to funding the most accomplished scientists in pancreatic cancer research, the foundation is attracting new researchers to the field.
Understanding the basic biology of pancreatic cancer enables the Foundation to get to the very core of the disease. Every aspect, from a cancer cell’s genes to the tumor’s environment, is under investigation. Lustgarten funded researchers are exploring the molecules that make up a cancer cell, how and why it transitions from normal to abnormal and why tumors react differently to various treatments. From discovery science to the clinic, Lustgarten Foundation funded researchers are investigating ways to detect the disease earlier, personalize treatments and develop better therapies.